InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Immunocore Holdings plc

IMCR Clue Score48
United Kingdom Fiscal year ends December CIK 0001671927 Results filed 6 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

26
Insider
Date
Role
Action
Shares
Price
Amount
David M Berman
5 Dec 2025
Head of R&D
Sold after exercise
572
$40.14
$22.96K
David M Berman
4 Dec 2025
Head of R&D
Sold after exercise
31,341
$40.26
$1.26M
David M Berman
28 Nov 2025
Head of R&D
Sold after exercise
5,521
$40.09
$221.34K
David M Berman
26 Nov 2025
Head of R&D
Sold after exercise
69,404
$40.12
$2.78M
David M Berman
25 Nov 2025
Head of R&D
Sold after exercise
18,020
$40.03
$721.34K
David M Berman
24 Nov 2025
Head of R&D
Sold after exercise
100
$40.00
$4.00K
David M Berman
30 Sep 2025
Head of R&D
Sold after exercise
61,849
$35.23
$2.18M
David M Berman
15 Sep 2025
Head of R&D
Sold after exercise
200
$35.01
$7.00K
David M Berman
12 Sep 2025
Head of R&D
Sold after exercise
1,300
$36.31
$47.20K
David M Berman
12 Sep 2025
Head of R&D
Sold after exercise
21,232
$35.63
$756.50K
David M Berman
11 Sep 2025
Head of R&D
Sold after exercise
19,081
$36.28
$692.26K
David M Berman
10 Sep 2025
Head of R&D
Sold after exercise
1,200
$36.77
$44.12K
David M Berman
10 Sep 2025
Head of R&D
Sold after exercise
30,138
$36.12
$1.09M
Leger Tina Amber St
1 Apr 2024
Chief HR Officer
Sold after exercise
4,375
$64.06
$280.26K
David M Berman
28 Feb 2024
Head of R&D
Sold after exercise
1,200
$70.45
$84.54K
David M Berman
28 Feb 2024
Head of R&D
Sold after exercise
10,937
$69.73
$762.64K
David M Berman
28 Feb 2024
Head of R&D
Sold after exercise
7,472
$68.84
$514.37K
David M Berman
28 Feb 2024
Head of R&D
Sold after exercise
16,900
$67.61
$1.14M
David M Berman
27 Feb 2024
Head of R&D
Sold after exercise
3,394
$71.97
$244.27K
David M Berman
27 Feb 2024
Head of R&D
Sold after exercise
25,944
$71.32
$1.85M
David M Berman
27 Feb 2024
Head of R&D
Sold after exercise
21,152
$70.42
$1.49M
David M Berman
27 Feb 2024
Head of R&D
Sold after exercise
4,448
$69.45
$308.91K
David M Berman
26 Feb 2024
Head of R&D
Sold after exercise
2,037
$71.31
$145.26K
David M Berman
26 Feb 2024
Head of R&D
Sold after exercise
26,516
$70.60
$1.87M
Leger Tina Amber St
3 Jan 2024
Chief HR Officer
Sold after exercise
307
$70.46
$21.63K
Leger Tina Amber St
3 Jan 2024
Chief HR Officer
Sold after exercise
4,068
$69.85
$284.15K
Show all 34 transactions →

What was left out

Form 4 filings counted 46
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 26
Sales at will 4
Transactions with no price 0
Shares from compensation/vesting 427,819
History held since 5 Jan 2024